Overview of Strimol plus
Strimol plus is a fixed-dose combination product containing two active synthetic ingredients, Acetaminophen (Paracetamol) and Caffeine, designed for the systemic relief of pain and fever. This medication is classified pharmacologically as a nonopioid Analgesic Combination with Antipyretic (fever-reducing) and Central Nervous System (CNS) Stimulant Adjuvant properties. It is administered via the oral route, typically available as a tablet or capsule.
Quick Facts
| Property | Description |
|---|---|
| Active ingredient | Acetaminophen (Paracetamol) and Caffeine |
| Form | Tablet or Capsule (Oral solid dosage form) |
| Pharmacological class | Analgesic Combination, Antipyretic |
| Common use | Relief of general body pain and feverish conditions |
| Origin | Synthetic |
Composition and Differentiation
The medication's primary components are the analgesic Acetaminophen and the Caffeine component, which acts as an adjuvant. The inclusion of Caffeine is clinically recognized for enhancing the overall pain-relieving action of Acetaminophen. This combination is often positioned for situations requiring robust relief, such as common headache or muscle aches.
This formulation is distinctive because it provides a mechanism beyond simple pain relief by incorporating a mild stimulant. This dual approach addresses both the physical pain and the accompanying feelings of fatigue often associated with symptoms. The specific combination is recognized as a standard method for providing effective relief from general aches and fever.
Core Therapeutic Purpose
The general therapeutic purpose of Strimol plus is to provide effective symptomatic relief from various types of pain and to reduce elevated body temperature associated with feverish conditions. This function relies on Acetaminophen increasing the body's pain threshold and regulating the hypothalamus to reduce fever. By combining the fever-reducing action of Acetaminophen with the stimulant-adjuvant properties of Caffeine, the product ensures a comprehensive approach to managing acute, non-chronic discomfort.
Regulatory References

